Erxi Wu

Associate Professor
Department of Pharmaceutical Sciences
TAMHSC Irma Lerma Rangel College of Pharmacy
United States of America

Biography

Erxi Wu did Research Associate in Medicine (1998-2004) from Dana-Farber Cancer Institute, Harvard Medical School. He did his Ph.D. (1995-1998) from Sheffield University Medical School.

Research Intrest

Cancer (brain tumors, neuroblastoma, pancreatic cancer, etc.) therapeutics targets, cancer stem cell biology, Therapeutics of neurodegenerative diseases, Blood biomarkers in cancer and other diseases, Drug binding targets, drug discovery, and natural products; Pharmacogenomics

List of Publications
Zhang H, Bajrazzewski N, Wu E, Wang H, Moseman AP, et al. (2007) PDGFRs are critical for PI3K/AKT activation and negatively regulated by mTOR. Journal of Clinical Investigation 117(3): 730-738.
Xia Z, Wang F, Zhou S, Zhang R, Wu E, et al. (2017) Catalpol protects synaptic proteins from beta-amyloid induced neuron injury and improves cognitive functions in aged rats. Oncotarget

Global Scientific Words in Pharmaceutical Sciences